Treatment burden — the workload associated with managing a disease, including taking medications, attending medical appointments, and carrying out self-care…
Articles by Steve Bryson, PhD
Projenx‘s prosetin was found to be safe and well tolerated at doses that engaged its therapeutic target in people…
The APOE4 gene variant, an established genetic risk factor for Alzheimer’s disease, may also influence how toxic TDP-43 protein…
A cellular recycling system that degrades damaged or unwanted proteins is impaired in motor neurons from people with amyotrophic…
A large-scale genetic analysis has identified several new rare mutations linked to amyotrophic lateral sclerosis (ALS), with findings suggesting…
Several commonly used medications may be repurposed to extend survival in people with amyotrophic lateral sclerosis (ALS), according to…
A triple combination therapy has shown promise for treating sporadic amyotrophic lateral sclerosis (ALS), according to a new study…
Scientists have developed a way to grow motor neurons, the highly specialized nerve cells that are lost in amyotrophic…
Health Canada has cleared the way for people with amyotrophic lateral sclerosis (ALS) living in Canada to join an…
Qalsody (tofersen) is one step closer to being covered by public Canadian healthcare systems when used to treat adults…